Treatment of mesothelioma: still a long way to go!

摘要：

Prognosis of patients with malignant pleural mesothelioma remains very poor.Single treatment modality is clearly not effective in improving disease-free and overall survival.For this reason combined modality therapy is intensively investigated.In the well-performed and timely systematic review by Cao and colleagues,results of trimodality therapy for mesothelioma consisting of neoadjuvant or adjuvant chemotherapy,extrapleural pneumonectomy and adjuvant radiotherapy,were evaluated (1).A total of 16 studies were included of which one was a randomized controlled trial,5 were prospective studies and the others selected retrospective,observational studies.Although the results are inconsistent,the authors conclude that trimodality therapy for mesothelioma may offer acceptable perioperative outcomes and long-term survival in selected patients who are treated in specialized centers (1).

机标关键词：randomized controlled trial、combined modality therapy、adjuvant radiotherapy、adjuvant chemotherapy、prospective studies、systematic review、overall survival

所属期刊栏目：25

分类号：R5 ;R76

在线出版日期：2013-07-08（万方平台首次上网日期，不代表论文的发表时间）

页数：共2页

页码：132-133